Study Protocol for an Open-Label, Single-Arm, Multicentre Phase II Trial to Evaluate the Efficacy and Safety of Combined Triplet Therapy and Olanzapine for Prevention of Carboplatin-Induced Nausea and Vomiting in Gynaecological Cancer Patients
BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-024357
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2019
Authors
Publisher
BMJ